• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care
Rare Disease : Episode 5

Episode 5 - Current Therapeutic Strategies for Hemophilia

Video

Systemic lupus erythematosus (SLE) is a complex autoimmune process with the potential to detrimentally impact every organ system in the human body. According to Dr. Michelle Petri, up to two-thirds of SLE cases are due to genetic predisposition, with SLE being more prevalent and severe among African- and Hispanic-Americans. The remaining one-third of cases may be attributed to environmental and hormonal components, with women being affected more than men in a 9:1 ratio. The implications of SLE are far-reaching, and it is important to develop a greater understanding of the disease to further improve current diagnostic and management strategies.

Related Videos
Eric Levin, Scripta
Margaret Krackeler, MD
Margaret Krackeler, MD
Margaret Krackeler, MD
A new study finds law enforcement presence in emergency departments may disrupt care. Lead author Prashasti Bhatnagar discusses policy and training solutions.
Jennifer Snow, MPA, NAMI
Jennifer Snow, MPA, NAMI
Dr Debra Patt
Most employees are unprepared to shop for coverage on their own, underscoring the need for stronger decision tools and consumer protections.
Related Content
pill with water -New Africa - stock.adobe.com

5 Things to Know About the Oral GLP-1 Era

February 6th 2026
Article

Oral semaglutide (Wegovy; Novo Nordisk) expands GLP-1 weight-loss options, but pharmacy budgets and health care cost pressures persist.

Read More

Managed Care Cast Square Image

The Orphan Drug Act in the Modern Drug Pricing Era

February 3rd 2026
Podcast

Policy strategist Kristi Martin discusses how the Orphan Drug Act reshapes rare disease treatment and drug-pricing challenges.

Listen

Debates at the International Stroke Conference 2026 centered on optimal treatment of ischemic stroke in the modern era. | Image credit: Aliaksandr Marko - stock.adobe.com

Is Less More After Thrombolysis? Debating Intensive Stroke Monitoring at ISC 2026

February 6th 2026
Article

In a pair of lively debates at the International Stroke Conference 2026, experts from around the world discussed controversies in stroke care.

Read More

Transparency in Coverage Data to Expose Ghost Rates and Hold Payers Accountable: David Muhlestein, PhD

Transparency in Coverage Data to Expose Ghost Rates and Hold Payers Accountable: David Muhlestein, PhD

January 20th 2026
Podcast

David Muhlestein, PhD, breaks down ghost rates, data gaps, and why stronger oversight is needed to make Transparency in Coverage files usable for patients.

Listen

Insulin syringe | Image Credit: © ixel-Shot-stock.adobe.com

Express Scripts Avoids Fines but Agrees to Major Structural Overhaul

February 5th 2026
Article

The FTC first sued Express Scripts, CVS Caremark, and Optum in 2024, claiming anticompetitive and unfair rebating practices surrounding insulin.

Read More

Many solutions to improve disparities in stroke care come down to appropriate tailoring for the target system and community. | Image credit: BJP7images - stock.adobe.com

Closing Gaps in Stroke Care Starts With Defining the US Health Care Safety Net

February 5th 2026
Article

Clearer definitions, tailored programs and policies, and telestroke care could help close rural stroke care disparities.

Read More

© 2026 MJH Life Sciences
AJMC®
All rights reserved.